thiazolidines has been researched along with dactolisib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ben-Salha, I; Costa, H; Echeverria, LMC; Freeman, A; Gately, KA; Haider, A; Heavey, S; Jameson, C; Kelly, JD; Kumar, C; Luszczak, S; Pye, H; Ratynska, M; Sathyadevan, VK; Shaw, G; Simpson, BS; Sridhar, A; Stopka-Farooqui, U; Whitaker, HC | 1 |
1 other study(ies) available for thiazolidines and dactolisib
Article | Year |
---|---|
Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
Topics: Antineoplastic Agents; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cohort Studies; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Male; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Pyridines; Pyrimidines; Quinolines; RNA, Messenger; Signal Transduction; Thiazolidines; Thiophenes; TOR Serine-Threonine Kinases | 2020 |